Literature DB >> 16910839

HIV genetic diversity in Cameroon: possible public health importance.

Clement B Ndongmo1, Danuta Pieniazek, Mona Holberg-Petersen, Carol Holm-Hansen, Leopold Zekeng, Stig L Jeansson, Lazare Kaptue, Marcia L Kalish.   

Abstract

To monitor the evolving molecular epidemiology and genetic diversity of HIV in a country where many distinct strains cocirculate, we performed genetic analyses on sequences from 75 HIV-1-infected Cameroonians: 74 were group M and 1 was group O. Of the group M sequences, 74 were classified into the following env gp41 subtypes or recombinant forms: CRF02 (n = 54), CRF09 (n = 2), CRF13 (n = 2), A (n = 5), CRF11 (n = 4), CRF06 (n = 1), G (n = 2), F2 (n = 2), and E (n = 1, CRF01), and 1 was a JG recombinant. Comparison of phylogenies for 70 matched gp41 and protease sequences showed inconsistent classifications for 18 (26%) strains. Our data show that recombination is rampant in Cameroon with recombinant viruses continuing to recombine, adding to the complexity of circulating HIV strains. This expanding genetic diversity raises public health concerns for the ability of diagnostic assays to detect these unique HIV mosaic variants and for the development of broadly effective HIV vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16910839     DOI: 10.1089/aid.2006.22.812

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  16 in total

1.  Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon.

Authors:  Jiangqin Zhao; Shixing Tang; Viswanath Ragupathy; Jean K Carr; Nathan D Wolfe; Bih Awazi; Indira Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09       Impact factor: 2.205

2.  Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa.

Authors:  Hiromi Imamichi; Ousmane Koita; Djeneba Dabitao; Sounkalo Dao; Mahamadou Ibrah; Dramane Sogoba; Robin L Dewar; Steve C Berg; Min-Kang Jiang; Mark Parta; Janice A Washington; Michael A Polis; H Clifford Lane; Anatole Tounkara
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

3.  Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in Italy.

Authors:  Nazle Mendonca Collaço Véras; Maria Mercedes Santoro; Rebecca R Gray; Andrew J Tatem; Alessandra Lo Presti; Flaminia Olearo; Giulia Cappelli; Vittorio Colizzi; Desiré Takou; Judith Torimiro; Gianluca Russo; Annapaola Callegaro; Romina Salpini; Roberta D'Arrigo; Carlo-Federico Perno; Maureen M Goodenow; Massimo Ciccozzi; Marco Salemi
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-06       Impact factor: 2.205

4.  Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.

Authors:  Aubin J Nanfack; Andrew D Redd; Jude S Bimela; Genesis Ncham; Emmanuel Achem; Andrew N Banin; Allison R Kirkpatrick; Stephen F Porcella; Lucy A Agyingi; Josephine Meli; Vittorio Colizzi; Arthur Nádas; Miroslaw K Gorny; Phillipe N Nyambi; Thomas C Quinn; Ralf Duerr
Journal:  J Clin Microbiol       Date:  2017-06-28       Impact factor: 5.948

5.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

6.  The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials.

Authors:  Rebecca Powell; Denis Barengolts; Luzia Mayr; Phillipe Nyambi
Journal:  Viruses       Date:  2010-02-12       Impact factor: 5.048

7.  Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B.

Authors:  Nicaise Ndembi; Awet Abraha; Heather Pilch; Hiroshi Ichimura; Dora Mbanya; Lazare Kaptue; Robert Salata; Eric J Arts
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

8.  Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States.

Authors:  S M Owen; C Yang; T Spira; C Y Ou; C P Pau; B S Parekh; D Candal; D Kuehl; M S Kennedy; D Rudolph; W Luo; N Delatorre; S Masciotra; M L Kalish; F Cowart; T Barnett; R Lal; J S McDougal
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

9.  The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations.

Authors:  Lucy Agyingi; Luzia M Mayr; Thompson Kinge; George Enow Orock; Johnson Ngai; Bladine Asaah; Mbida Mpoame; Indira Hewlett; Phillipe Nyambi
Journal:  J Med Virol       Date:  2013-11-19       Impact factor: 2.327

10.  Lipid peroxidation and total cholesterol in HAART-naïve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon.

Authors:  Georges Teto; Georgette D Kanmogne; Judith N Torimiro; George Alemnji; Flore N Nguemaim; Désiré Takou; Aubin Nanfack; Asonganyi Tazoacha
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.